Mortgage Lender loanDepot Receives NYSE Warning Over Sub-$1 Share Price
loanDepot, Inc. received a deficiency notice from the NYSE because its Class A common stock traded below $1 for 30 consecutive days, signaling financial challenges for the nonbank lender. This notice triggers a plan to regain compliance but does not immediately affect trading.
The short version
- loanDepot, Inc. (NYSE: LDI) received a deficiency notice from the New York Stock Exchange on August 21, 2026.
- The notice was issued because loanDepot's Class A common stock traded below an average closing price of $1.00 per share for 30 consecutive trading days, ending August 20, 2026.
- The company's stock has lost 54.4% over the past 12 months, trading as low as $0.83 within its 52-week range.
- The NYSE notice does not immediately impact loanDepot's listing, trading, daily operations, or SEC reporting obligations.
- loanDepot must submit a plan to regain compliance to the NYSE within 10 business days and has a six-month period to meet the listing requirements.
Irvine, California-based nonbank lender loanDepot, Inc. (NYSE: LDI) has received a deficiency notice from the New York Stock Exchange (NYSE) for failing to maintain a minimum share price. The notice, issued on August 21, 2026, came after loanDepot's Class A common stock traded below an average closing price of $1.00 per share for 30 consecutive trading days, a period that concluded on August 20, 2026, as reported by HousingWire, Investing.com Canada, and StreetInsider.
While this notice flags a critical compliance issue, it does not immediately affect the company's NYSE listing, its stock's trading status, day-to-day operations, or Securities and Exchange Commission (SEC) reporting obligations. However, it initiates a formal process for loanDepot to regain compliance with the exchange's listing standards.
Why Did loanDepot Receive This Notice?
The deficiency notice stems directly from loanDepot's prolonged struggle to keep its stock price above the NYSE's minimum threshold. The company's journey began with its IPO in February 2021 at $14 per share. Fast forward to today, the stock has seen a significant decline, losing 54.4% over the past 12 months alone. On August 19, 2026, LDI was trading at $0.86 per share, a stark contrast to its $1.12 closing price on July 14, 2026, and far below its 52-week high of $5.05. The stock's 52-week trading range bottomed out at $0.83.
Amidst these challenges, loanDepot founder and CEO Anthony Hsieh stated, "As we continue to execute our transformation agenda to position loanDepot for profitable market share growth, we are making significant progress." He further elaborated, "We are making more loans, making them faster, and producing them at a lower cost," highlighting recent quarterly gains including a 25% increase in unit volume, an 18% rise in revenue, and a 33% boost in purchase market share.
What Do loanDepot's Recent Financials Show?
The company's financial performance leading up to the NYSE notice paints a mixed picture, reflecting both ongoing struggles and recent improvements. For Q1 2026, announced on May 5, 2026, loanDepot reported a net loss of $55 million, an increase from $33 million in Q4 2025. Adjusted net loss for Q1 2026 was $34 million, with revenue at $286 million, an 8% decrease from Q4 2025. Diluted loss per share was $(0.16), significantly missing the consensus estimate of $(0.0404).
However, loanDepot showed signs of recovery in its Q2 2026 results, announced on August 4, 2026. The net loss improved substantially to $6.6 million, a notable reduction from the $54.9 million loss in Q1 2026. Revenue also saw an upturn, reaching $337.3 million, an 18% increase from Q1 2026.
Despite these improvements, the company continues to navigate a difficult landscape, citing challenging mortgage market conditions, elevated operating costs, a limited supply of new and resale homes, and persistent market volatility affecting demand and interest rates, as well as geopolitical uncertainty.
Is There Investor Pressure on loanDepot?
Yes, loanDepot has also faced public pressure from activist investors. On July 16, 2026, Randian Capital, a retail activist investment firm with economic exposure to over 250,000 loanDepot shares, issued an open letter to the company's board. The letter urged loanDepot to explore strategic alternatives, including a potential sale, arguing that the company's "prolonged underperformance" could not be solely attributed to macroeconomic factors.
What Happens Next for loanDepot?
To address the NYSE deficiency, loanDepot must submit a plan to regain compliance within 10 business days of receiving the notice. Following this, the company enters a six-month "cure period" from the date of the notice. During this time, loanDepot's Class A common stock must achieve a closing price of $1.00 or more for at least 30 consecutive trading days to satisfy the NYSE's continued listing standards. Failure to meet this requirement within the stipulated timeframe could ultimately lead to the delisting of loanDepot's stock from the New York Stock Exchange.
Frequently asked questions
What does a NYSE deficiency notice mean for loanDepot's stock?
The notice signifies that loanDepot's stock price has fallen below the NYSE's minimum listing requirement of $1.00 for 30 consecutive trading days. It does not immediately result in delisting but triggers a formal process for the company to regain compliance.
What is loanDepot required to do to regain compliance?
loanDepot must submit a plan to the NYSE within 10 business days explaining how it intends to resolve the deficiency. The company then has a six-month "cure period" to achieve a closing share price of $1.00 or higher for at least 30 consecutive trading days.
Reported by the RevReck Newsroom from the reporting linked below, with AI assistance in drafting, under editorial rules covering accuracy, attribution and what we will not publish. Read our editorial standards, or email corrections to operations@revreck.com.